Glucosamine
- Generic Name
- Glucosamine
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C6H13NO5
- CAS Number
- 3416-24-8
- Unique Ingredient Identifier
- N08U5BOQ1K
- Background
Osteoarthritis (OA) is a progressive and degenerative joint disease marked by loss of cartilage, bone changes, and synovial membrane inflammation. Treatment with chondroprotective drugs, such as glucosamine sulfate may offer additional benefits to nonsteroidal anti-inflammatory drugs treating the painful symptoms of OA. Glucosamine is commonly used over the ...
- Indication
Glucosamine is generally used over the counter in the symptomatic treatment of osteoarthritis and joint pain, frequently combined with chondroitin sulfate and/or ibuprofen.
- Associated Conditions
- Back pain, Joint Pain, Osteoarthritis (OA), Osteoarthritis of the Knee, Articular inflammation
- Associated Therapies
- -
Study of Association of Anti-inflammatory and Anti-rheumatic
- Conditions
- Interventions
- First Posted Date
- 2015-05-19
- Last Posted Date
- 2015-05-19
- Lead Sponsor
- Zodiac Produtos Farmaceuticos S.A.
- Target Recruit Count
- 375
- Registration Number
- NCT02448199
Glucosamine and Chondroitin for Aromatase Inhibitor Induced Joint Symptoms in Women With Breast Cancer
- First Posted Date
- 2008-06-05
- Last Posted Date
- 2022-11-08
- Lead Sponsor
- Dawn L. Hershman
- Target Recruit Count
- 53
- Registration Number
- NCT00691678
- Locations
- 🇺🇸
Columbia University, New York, New York, United States
Absorption and Distribution of Glucosamine and Chondroitin
- Conditions
- First Posted Date
- 2004-06-29
- Last Posted Date
- 2006-08-18
- Target Recruit Count
- 70
- Registration Number
- NCT00086229
- Locations
- 🇺🇸
University of Utah Health Sciences Center, Salt Lake City, Utah, United States
Glucosamine/Chondroitin Arthritis Intervention Trial (GAIT)
- Conditions
- First Posted Date
- 2002-04-08
- Last Posted Date
- 2009-01-21
- Lead Sponsor
- US Department of Veterans Affairs
- Target Recruit Count
- 1588
- Registration Number
- NCT00032890
- Locations
- 🇺🇸
*Indiana University School of Medicine, Indianapolis, Indiana, United States
🇺🇸*Case Western Reserve University, Beachwood, Ohio, United States
🇺🇸Arthritis Consultation Center, Dallas, Texas, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.